[Congenital deficiencies in bile acid synthesis: from diagnosis to treatment].
Bile acids represent the principal excretion pathway of cholesterol. Their synthesis involves hydroxylations of the sterol nucleus and shortening of the lateral chain transforming an highly insoluble and immiscible molecule in an hydrophilic and detergent one. Congenital defect of one of the enzymes of bile acid synthesis (26-alpha-hydroxylase) constitutes the etiology of cerebrotendinous xanthomatosis, associating degenerative disease of the central nervous system, cutaneous xanthomas and cataract; the degenerative process may be stopped by a substitutive therapy with chenodeoxycholic acid. In another syndrome characterised by a lack of peroxisomes (Zellweger disease and associated syndromes), some bile acid metabolites accumulate due to the enzymatic block. Some cases of malabsorption due to a congenital defect of bile sterol synthesis are reported; such a case was jointly investigated in Brussels and Groningen.
Service de Biologie Clinique, Hôpital Ambroise Paré, Mons.
J
J
Vanderpas
D002493:Central Nervous System Diseases / Q000378:metabolism*; D002635:Chenodeoxycholic Acid / Q000627:therapeutic use; D053493:Cholestanetriol 26-Monooxygenase; D002784:Cholesterol / Q000096:biosynthesis* / Q000172:deficiency; D003577:Cytochrome P-450 Enzyme System / Q000172:deficiency*; D006801:Humans; D008052:Lipid Metabolism, Inborn Errors / Q000188:drug therapy / Q000378:metabolism*; D013250:Steroid Hydroxylases / Q000172:deficiency*; D014973:Xanthomatosis / Q000378:metabolism; D015211:Zellweger Syndrome / Q000188:drug therapy / Q000378:metabolism
D002635:Chenodeoxycholic Acid; D003577:Cytochrome P-450 Enzyme System; D002784:Cholesterol; D013250:Steroid Hydroxylases; C506831:CYP27A1 protein, human; D053493:Cholestanetriol 26-Monooxygenase
Les déficits congénitaux de synthèse des acides biliaires: du diagnostic au traitement.